These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26557834)

  • 61. Review article: the diagnosis and management of Crohn's disease in populations with high-risk rates for tuberculosis.
    Epstein D; Watermeyer G; Kirsch R
    Aliment Pharmacol Ther; 2007 Jun; 25(12):1373-88. PubMed ID: 17539977
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pathogenesis of fibrostenosing Crohn's disease.
    Li J; Mao R; Kurada S; Wang J; Lin S; Chandra J; Rieder F
    Transl Res; 2019 Jul; 209():39-54. PubMed ID: 30981697
    [TBL] [Abstract][Full Text] [Related]  

  • 63. IOIBD technical review on endoscopic indices for Crohn's disease clinical trials.
    Vuitton L; Marteau P; Sandborn WJ; Levesque BG; Feagan B; Vermeire S; Danese S; D'Haens G; Lowenberg M; Khanna R; Fiorino G; Travis S; Mary JY; Peyrin-Biroulet L
    Gut; 2016 Sep; 65(9):1447-55. PubMed ID: 26353983
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Length and type of recurrent ileitis after ileal resection correlate with presurgical features in Crohn's disease.
    Dʼhaens G; Baert F; Gasparaitis A; Hanauer S
    Inflamm Bowel Dis; 1997; 3(4):249-53. PubMed ID: 23282870
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Chronic inflammatory bowel diseases: state of the art].
    Maul J; Siegmund B
    Dtsch Med Wochenschr; 2014 Sep; 139(36):1771-5. PubMed ID: 25157865
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical trials in luminal Crohn's disease: a historical perspective.
    Hindryckx P; Baert F; Hart A; Armuzzi A; Panès J; Peyrin-Biroulet L;
    J Crohns Colitis; 2014 Nov; 8(11):1339-50. PubMed ID: 24841216
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The -295T-to-C promoter polymorphism of the IL-16 gene is associated with Crohn's disease.
    Glas J; Török HP; Unterhuber H; Radlmayr M; Folwaczny C
    Clin Immunol; 2003 Mar; 106(3):197-200. PubMed ID: 12706406
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inflammatory bowel disease. Part II: Clinical and therapeutic aspects.
    Kirsner JB
    Dis Mon; 1991 Nov; 37(11):669-746. PubMed ID: 1935537
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epidemiology of Crohn's disease of the colon.
    de Dombal FT
    Ann Gastroenterol Hepatol (Paris); 1985; 21(4):191-200. PubMed ID: 4073819
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In favour of prophylactic treatment for post-operative recurrence in Crohn's disease.
    Caprilli R; Taddei G; Viscido A
    Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):219-25. PubMed ID: 9675663
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Secondary (AA) amyloidosis in Crohn's disease].
    Bulum T; Prkacin I; Cavrić G; Sobocan N; Skurla B; Duvnjak L; Bulimbasić S
    Acta Med Croatica; 2011; 65(3):271-8. PubMed ID: 22359896
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Crohn's disease.
    Torres J; Mehandru S; Colombel JF; Peyrin-Biroulet L
    Lancet; 2017 Apr; 389(10080):1741-1755. PubMed ID: 27914655
    [TBL] [Abstract][Full Text] [Related]  

  • 73. New horizons in the imaging of perianal Crohn's disease: transperineal ultrasonography.
    Bezzio C; Bryant RV; Manes G; Maconi G; Saibeni S
    Expert Rev Gastroenterol Hepatol; 2017 Jun; 11(6):523-530. PubMed ID: 28319427
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The role of topical therapy for perianal fistulizing Crohn's disease: are we forgetting something?
    Ribaldone DG; Resegotti A; Pellicano R; Astegiano M; Saracco GM; Morino M
    Minerva Gastroenterol Dietol; 2019 Jun; 65(2):130-135. PubMed ID: 30759975
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Risk factors for recurrence after bowel resection for Crohn's disease.
    Chen ZX; Chen YL; Huang XM; Lin XT; He XW; Lan P
    World J Gastrointest Pharmacol Ther; 2019 Oct; 10(4):67-74. PubMed ID: 31692953
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Early treatment in Crohn's disease: do we have enough evidence to reverse the therapeutic pyramid?
    Fascì Spurio F; Aratari A; Margagnoni G; Doddato MT; Papi C
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):67-73. PubMed ID: 22457862
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Eosinophils and IL-33 Perpetuate Chronic Inflammation and Fibrosis in a Pediatric Population with Stricturing Crohn's Ileitis.
    Masterson JC; Capocelli KE; Hosford L; Biette K; McNamee EN; de Zoeten EF; Harris R; Fernando SD; Jedlicka P; Protheroe C; Lee JJ; Furuta GT
    Inflamm Bowel Dis; 2015 Oct; 21(10):2429-40. PubMed ID: 26218140
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Natalizumab for induction of remission in Crohn's disease.
    MacDonald JK; McDonald JW
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006097. PubMed ID: 17253580
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Noncanonical STAT3 activation regulates excess TGF-β1 and collagen I expression in muscle of stricturing Crohn's disease.
    Li C; Iness A; Yoon J; Grider JR; Murthy KS; Kellum JM; Kuemmerle JF
    J Immunol; 2015 Apr; 194(7):3422-31. PubMed ID: 25740948
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease.
    Fedorak RN; Feagan BG; Hotte N; Leddin D; Dieleman LA; Petrunia DM; Enns R; Bitton A; Chiba N; Paré P; Rostom A; Marshall J; Depew W; Bernstein CN; Panaccione R; Aumais G; Steinhart AH; Cockeram A; Bailey RJ; Gionchetti P; Wong C; Madsen K
    Clin Gastroenterol Hepatol; 2015 May; 13(5):928-35.e2. PubMed ID: 25460016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.